COVID-19 vaccine over Moderna due to a very low incidence of cardio issues in some younger people.The recommendation was made based on the advice of Ontario’s Children COVID-19 Vaccine Table, Ontario Vaccine Clinical Advisory Group and Public Health Ontario.“This is due to an observed increase in Ontario of the very rare heart condition called pericarditis/myocarditis following vaccination with Moderna compared to Pfizer in the 18 to 24 year old age group, particularly among males,” the government said on Wednesday.
Pfizer, Moderna COVID-19 vaccines get full Health Canada approval — and new names According to data released on Wednesday, the risk of the development of the heart condition is 1 in 5,000 for males aged 18 to 24 following a.